Technical Analysis for RARE - Ultragenyx Pharmaceutical Inc.

Grade Last Price % Change Price Change
D 118.14 -0.41% -0.49
RARE closed down 5.32 percent on Thursday, March 4, 2021, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical RARE trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness -0.41%
Multiple of Ten Bearish Other -0.41%
Wide Bands Range Expansion -0.41%
Below Lower BB Weakness -0.41%
Down 3 Days in a Row Weakness -0.41%
Lower Bollinger Band Touch Weakness -0.41%
Oversold Stochastic Weakness -0.41%
Multiple of Ten Bearish Other -5.71%
Wide Bands Range Expansion -5.71%
Below Lower BB Weakness -5.71%
Older End-of-Day Signals for RARE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 3 hours ago
Down 5% about 3 hours ago
Rose Above Lower Bollinger Band about 4 hours ago
Down 3% about 4 hours ago
Down 2 % about 4 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Ultragenyx Pharmaceutical Inc. Description

Ultragenyx Pharmaceutical Inc., a development-stage biotechnology company, focuses on the identification, acquisition, development, and commercialization of various products for the treatment of rare and ultra-rare diseases in the United States. It develops various biologics product candidates, including KRN23, a human monoclonal antibody to bind and reduce the biological activity of fibroblast growth factor to enhance abnormally low phosphate levels in patients with X-linked hypophosphatemia; recombinant human beta-glucuronidase, an intravenous enzyme replacement therapy for the treatment of mucopolysaccharidosis 7; and recombinant human protective protein cathepsin-A, an enzyme replacement therapy for galactosialidosis. The company is also developing a range of small-molecule product candidates comprising triheptanoin, a substrate replacement therapy for patients with fatty acid oxidation disorders, as well as for patients with glucose transporter type-1 deficiency syndrome; and oral formulation of sialic acid to treat hereditary inclusion body myopathy. It has license agreements with AAI Pharma Services Corp. and HIBM Research Group; and a collaboration and license agreement with Nobelpharma Co., Ltd. The company was founded in 2010 and is headquartered in Novato, California.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Acid Pharmacy Monoclonal Antibody Rare Diseases Phosphate Glucose Fatty Acid Myopathy Fibroblast Growth Factor Transporter Enzyme Replacement Therapy Ibm Molecule Product Mucopolysaccharidosis Biologics Product Deficiency Syndrome Biologics Pharma Services Rare And Ultra Rare Diseases

Is RARE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 179.647
52 Week Low 31.99
Average Volume 463,021
200-Day Moving Average 105.52
50-Day Moving Average 146.52
20-Day Moving Average 147.07
10-Day Moving Average 137.99
Average True Range 8.46
ADX 15.89
+DI 16.06
-DI 36.35
Chandelier Exit (Long, 3 ATRs ) 149.63
Chandelier Exit (Short, 3 ATRs ) 141.81
Upper Bollinger Band 172.95
Lower Bollinger Band 121.19
Percent B (%b) -0.05
BandWidth 35.20
MACD Line -4.66
MACD Signal Line -1.56
MACD Histogram -3.0956
Fundamentals Value
Market Cap 7.85 Billion
Num Shares 66.2 Million
EPS -7.01
Price-to-Earnings (P/E) Ratio -16.93
Price-to-Sales 34.13
Price-to-Book 12.33
PEG Ratio -0.24
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 133.19
Resistance 3 (R3) 134.08 130.11 130.76
Resistance 2 (R2) 130.11 126.40 129.67 129.95
Resistance 1 (R1) 124.37 124.11 122.39 123.48 129.14
Pivot Point 120.41 120.41 119.41 119.96 120.41
Support 1 (S1) 114.67 116.70 112.68 113.78 108.12
Support 2 (S2) 110.70 114.41 110.26 107.31
Support 3 (S3) 104.96 110.70 106.50
Support 4 (S4) 104.07